1. Home
  2. ATOS vs HAIN Comparison

ATOS vs HAIN Comparison

Compare ATOS & HAIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atossa Therapeutics Inc.

ATOS

Atossa Therapeutics Inc.

HOLD

Current Price

$4.24

Market Cap

83.3M

Sector

Health Care

ML Signal

HOLD

Logo Hain Celestial Group Inc. (The)

HAIN

Hain Celestial Group Inc. (The)

HOLD

Current Price

$0.95

Market Cap

95.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATOS
HAIN
Founded
2009
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
83.3M
95.1M
IPO Year
2012
1993

Fundamental Metrics

Financial Performance
Metric
ATOS
HAIN
Price
$4.24
$0.95
Analyst Decision
Strong Buy
Hold
Analyst Count
3
10
Target Price
$31.67
$2.76
AVG Volume (30 Days)
256.9K
2.9M
Earning Date
03-24-2026
02-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,505,702,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$0.39
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.76
$0.82
52 Week High
$19.35
$4.84

Technical Indicators

Market Signals
Indicator
ATOS
HAIN
Relative Strength Index (RSI) 65.41 38.25
Support Level $3.76 $0.82
Resistance Level $5.54 $1.25
Average True Range (ATR) 0.48 0.12
MACD 0.07 -0.04
Stochastic Oscillator 49.34 20.82

Price Performance

Historical Comparison
ATOS
HAIN

About ATOS Atossa Therapeutics Inc.

Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.

About HAIN Hain Celestial Group Inc. (The)

The Hain Celestial Group Inc is a health and wellness company. It makes natural and organic food and personal-care products. The company offers products across various categories such as snacks, baby & kids food, beverages, meal preparation, and personal care through brands like Garden Veggie Snacks, Terra chips, Garden of Eatin snacks, Hartley's Jelly, and Celestial Seasonings teas, among others. It operates under two reportable segments: North America and International. The majority of its revenue is derived from the North America segment, which represents the sale of its products in the United States and Canada. The International segment includes the sale of its products in the United Kingdom and the Western European region.

Share on Social Networks: